3 Days
Source:
المشهد
US Approves Low-Cost PrEP
The U.S. Food and Drug Administration has tentatively approved a low-cost generic version of lenacapavir, a drug for HIV prevention given by injection twice a year. Made by India’s Dr. Reddy’s, the generic will be available for $40 per person per year in 120 countries, compared with about $28,000 a year for the drug in the United States. Clinical trials showed the drug was more than 99.9% effective.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)